Autobio Diagnostics Co., Ltd.
603658
Rankning i aktier
#4904
Autobio Diagnostics Co., Ltd. specializes in the full lifecycle of clinical... Autobio Diagnostics Co., Ltd. specializes in the full lifecycle of clinical diagnostic products, from their initial research and development to manufacturing and market distribution. Their diverse offerings encompass a range of reagents for immunoassay, biochemistry, microbiology, and in-vitro diagnostics (IVD). Additionally, they provide advanced automated and semi-automated instrumentation, alongside comprehensive medical laboratory solutions. Notable immunoassay products include the AutoLumo A2000 Plus automatic chemiluminescence immunoassay analyzer, automated microplate chemiluminescent enzyme immunoassays, LUmo luminometers, PHOmo microplate readers, and iWO microplate washers. Within their microbiology division, they offer automated blood culture systems, blood culture bottles, AUTOMIC strips, and mycoplasma IES. Founded in 1998, the company originally operated as Lifeclone Diagnostics Co., Ltd. before adopting its current name, Autobio Diagnostics Co., Ltd., in 2003. Headquartered in Zhengzhou, China, it functions as a subsidiary of Zhengzhou Auto Industrial Co., Ltd.
Aktiekurs
$5.15
Senast synkroniserad: 2026-10-22
Marknadsvärde
$2.94B
Förändring (1 dag)
0.97%
Förändring (1 år)
-5.80%
Land
CN
Handel Autobio Diagnostics Co., Ltd. (603658)
Kategori
Healthcare
Antal utestående aktier för Autobio Diagnostics Co., Ltd. (603658)
Antal utestående aktier per June 2026: 571.42M
Enligt de senaste finansiella rapporterna och aktiekursen för Autobio Diagnostics Co., Ltd. är det aktuella antalet utestående aktier 571.42M. I slutet av December 2024 hade företaget 577.03M utestående aktier. Antalet utestående aktier påverkas vanligtvis av aktiesplit och återköp av aktier.
Historik över utestående aktier för Autobio Diagnostics Co., Ltd. (603658) från 2011 till 2026
Utestående aktier vid slutet av varje år
| År | Utestående aktier | Ändra |
|---|---|---|
| 2026 (TTM) | 571.42M | 0.05% |
| 2025 | 571.13M | -1.02% |
| 2024 | 577.03M | -0.47% |
| 2023 | 579.73M | -0.68% |
| 2022 | 583.72M | -0.44% |
| 2021 | 586.27M | 5.06% |
| 2020 | 558.06M | 2.21% |
| 2019 | 546.00M | 0.04% |
| 2018 | 545.76M | -0.04% |
| 2017 | 546.00M | 6.87% |
| 2016 | 510.88M | 4.60% |
| 2015 | 488.43M | -0.75% |
| 2014 | 492.13M | 0.69% |
| 2013 | 488.78M | -2.21% |
| 2012 | 499.84M | -14.74% |
| 2011 | 586.27M | 0.00% |
Utestående aktier för liknande företag eller konkurrenter
| Företag | Utestående aktier | Skillnad | Land |
|---|---|---|---|
| 370.00M | -35.25% |
US
|
|
| 703.80M | 23.17% |
US
|
|
| 143.28M | -74.93% |
US
|
|
| 2.91B | 409.06% |
CN
|
|
| 282.00M | -50.65% |
US
|
